Introduction
Aspergillus fumigatus is a ubiquitous soil fungus found in decaying organic matter and can cause invasive infections in people with compromised immune systems such as those receiving immunosuppressive medication or transplant recipients. 1 The azole antifungal voriconazole is first-line therapy for the treatment of invasive aspergillosis. 2 Before voriconazole became available in 2002, itraconazole was the azole of choice for treating aspergillosis and it is still used in countries where voriconazole availability is limited. Recently, a unique mechanism of resistance to the azole antifungals in A. fumigatus was identified. [3] [4] [5] [6] It was first identified in Europe from patients with A. fumigatus infections that were refractory to treatment; subsequently it was identified in isolates recovered from environmental sources in areas where agricultural azoles had been sprayed on crops. 3, [7] [8] [9] The link between clinical resistance and agricultural azoles was strengthened when it was shown that agricultural azoles could confer cross-resistance to medical azoles in A. fumigatus.
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Resistance has been subsequently identified in Asia, the Middle East, Africa, Australia and South America. 7, 8, [11] [12] [13] [14] [15] [16] In the Netherlands, where the increase in resistance was first noted, azole resistance has risen to 5%-10% of all invasive aspergillosis cases and is as high as 30% in some high-risk wards. 17 The unique resistance mechanism is an indel that consists of both a 34 bp tandem repeat in the promoter region of CYP51A, the azole target gene, and a substitution of leucine for histidine at codon 98 (denoted as TR 34 /L98H). The combination of these two mutations confers cross-resistance to the clinical azole antifungals. 3 A second combination indel-substitution also specifically associated with isolates from the environment, TR 46 /Y121F/T289A, was first detected in Europe and was soon identified in Asia and South America as well. 14, 18, 19 An initial survey of 1026 A. fumigatus isolates collected from clinics throughout the USA from 2011 to 2013 did not identify any isolates with either the TR 34 /L98H or the TR 46 /Y121F/T289A mutation. 20 However, a report describing four patient isolates, two with TR 34 /L98H and two with TR 46 /Y121F/T289A, was published in 2015 21 followed by another report describing a third case of a patient isolate containing the TR 46 /Y121F/T289A mutation. 22 In an effort to determine whether isolates containing TR 34 /L98H or TR 46 /Y121F/T289A could exist in the environment in the USA, we sampled crop debris from peanut fields with a history of exposure to the agricultural azoles tebuconazole and propiconazole, two of
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Materials and methods
Environmental sampling, recovery, identification and susceptibility testing of A. fumigatus
Environmental sampling was carried out in experimental fields on University of Georgia experimental research farms (Tift County, GA, USA) in November 2015 after the crop harvest. A total of 34 specimens were collected from four separate peanut fields that had been sprayed with azole fungicides. Recent harvest crop debris and soils were collected from each of the four fields. In addition, the harvest debris from the previous years was collected from a single large compost pile, to which debris from individual fields had been deposited and composted for multiple years. Samples were taken from the interior of the pile. Isolation of A. fumigatus from crop debris specimens was accomplished by adding 30 mL of a sterile 0.1 M solution of sodium pyrophosphate to the collection jar, which was vortexed vigorously for 30 s. The jar was allowed to sit for 1 min; 10 and 100 lL of the supernatant were each plated on two Sabouraud dextrose agar (SDA) plates supplemented with chloramphenicol (0.05 mg/L) and gentamicin (0.05 mg/L). Plates were incubated at 45 C for up to 7 days and colonies were harvested when they were 2-4 mm in diameter. The plated volume of supernatant was adjusted if necessary in a subsequent plating for each sample to achieve ,10 total colonies per plate. The isolates were preliminarily identified by macroscopic and microscopic morphology and definitive identification was made by sequencing the tubulin gene as previously described. 24 Isolates were screened for resistance by plating on SDA containing 4 mg/L itraconazole. In addition some supernatants were plated directly onto SDA plates containing 4 mg/L voriconazole. Susceptibility testing of the isolates was performed by broth microdilution according to CLSI document M38-A2. 25 Amplification of the CYP51A gene Genomic DNA was extracted from mycelium as previously described. 13 The CYP51A gene and promoter were amplified using two primers and sequenced using eight additional primers as described previously. 20 The CYP51A sequence from A. fumigatus strain 237 (GenBank accession number AF338659) was used as the WT reference.
Microsatellite analysis
Isolates were genotyped by microsatellite analysis using the nine primer sets STRAF2a, STRAF2b, STRAF3a, STRAF3b, STRAF4a, STRAF4b, BDA, BDB and BDD as previously described. 26, 27 eBURST analysis of microsatellite results was accomplished using eBURST V3 Imperial College London. 28 
Results
Out of the 34 environmental specimens that were collected, no A. fumigatus was isolated from 26 of them, including all of the recent harvest piles and soil from the individual fields. A total of 200 isolates of A. fumigatus were grown from eight specimens collected at different spots from a large compost pile containing peanut plant harvest debris from multiple fields that had accumulated over several years. Of these 200 isolates, 38 (19%) were able to grow on medium containing 4 mg/L itraconazole. Susceptibility testing confirmed the 38 isolates were resistant to itraconazole with MIC values of 16 mg/L and voriconazole MICs ranging from 0.5 to 4 mg/L. Sequencing of the CYP51A gene revealed 20 of the itraconazole-resistant isolates contained TR 34 /L98H and none contained TR 46 /Y121F/T289A.
To screen specifically for TR 46 /Y121F/T289A, specimens from the large debris piles were plated directly onto SDA containing 4 mg/L voriconazole. Eighteen additional azole-resistant A. fumigatus isolates were identified. None of those isolates possessed TR 46 /Y121F/ T289A and only one possessed TR 34 /L98H. However, four possessed at least one mutation known to be in the CYP51A genes of both susceptible and resistant isolates, such as F46Y/M172V/N248T/D255E/ E427K, I242V and G254V (data not shown).
To determine the genetic relatedness of the isolates, microsatellite typing was performed on 51 of the isolates, 30 of which contained the TR 34 /L98H mutation. Of these 30 isolates with the TR 34 /L98H mutation, 22 (73%) were identical by microsatellite typing, suggesting they were clonal in origin. An additional six isolates differed from the clonal group by a single locus (a different locus for each of the six isolates), one more was different by two loci and one TR 34 /L98H isolate had a completely unrelated microsatellite pattern (Figure 1 ). By contrast, the majority of the susceptible isolates had a unique microsatellite pattern, indicative of a complex population structure of A. fumigatus.
Discussion
This article demonstrates that TR 34 /L98H azole-resistant A. fumigatus isolates can be found in an agricultural setting in the USA. This surveillance was not meant to be comprehensive or quantitative. Further strategic sampling in agricultural and non-agricultural areas should be conducted to assess the geographical boundaries of A. fumigatus resistance. It will also be important to better understand the structure of A. fumigatus natural populations in the USA to determine whether isolates with the TR 34 /L98H mutation have been introduced from other sources or originated locally in the USA. A more comprehensive typing system like WGS may be able to distinguish between these two possibilities. 29 Although there have only been a few patients with disease caused by azole-resistant isolates with this mutation in the USA, 21 there needs to be heightened awareness among Hurst et al.
healthcare providers about possible resistance in patients with invasive aspergillosis. It is important to note that several studies have demonstrated that patients can be coinfected or co-colonized by both resistant and susceptible isolates at the same time, so culturing a susceptible isolate from a patient with a refractory infection does not rule out the presence of a resistant isolate. 30, 31 While susceptibility testing of all isolates of A. fumigatus is not currently recommended in the USA by the IDSA, 2 it should be considered when patients have aspergillosis that is refractory to azole treatment. 32 Further surveillance and study for azole-resistant A. fumigatus is needed in both clinical and environmental areas in the USA.
